Sleep and Breathing Disturbance Secondary to Nasal Obstruction

Olsen, Kerry D.; Kern, Eugene B.; Westbrook, Philip R.

doi:10.1177/019459988108900522

Cited by 221 publications

(116 citation statements)

References 6 publications

Supporting

Mentioning

110

Contrasting

Unclassified

Order By: Relevance

“…Poorly-controlled symptoms of allergic rhinitis may contribute to sleep loss or disturbance (94,96,(98)(99)(100)(101)(102)(103)(104). Moreover, sedation in patients with allergic rhinitis may be increased by using sedative treatments (105,106).…”

Section: Sleep Disturbancementioning

confidence: 99%

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

Bousquet¹,

Khaltaev²,

Cruz³

et al. 2008

Allergy

3,861

1,761

View full text Add to dashboard Cite

Section: Sleep Disturbancementioning

confidence: 99%

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

Bousquet¹,

Khaltaev²,

Cruz³

et al. 2008

Allergy

3,861

1,761

View full text Add to dashboard Cite

“…24,25 Studies in normal subjects demonstrate that nasal breathing increases ventilation by stimulating certain receptors in the nasal airway, and that occlusion of the nasal airway may produce decreased oropharyngeal patency. [26][27][28] Therefore, the nasal congestion associated with AR can limit maximal upper airway airflow and contribute to sleep disturbances. 29 Specific types of sleep disturbances or sleep-disordered breathing (SDB) related to increased airway resistance include snoring, upper airway resistance syndrome, and obstructive sleep apnoea syndrome.…”

Section: Mechanisms Of Nasal Congestion: Impact On Sleep Quality and mentioning

confidence: 99%

Allergic rhinitis-induced nasal congestion: its impact on sleep quality

Storms¹

2008

Primary Care Respiratory Journal

View full text Add to dashboard Cite

Allergic rhinitis (AR) is an extremely common health problem affecting 20 to 40 million Americans and between 10-25% of the world's population. Patients with AR suffer from both nasal symptoms (congestion, rhinorrhea, itching, and sneezing) and ocular symptoms (itching, redness, and tearing). The negative impact on sleep quality and quantity, and consequently on various aspects of the patient's life, is an under-recognised and under-treated component of AR morbidity. Nasal congestion, which is one of the most bothersome and prevalent symptoms of AR, is thought to be the leading symptom responsible for rhinitis-related sleep problems.In addition to reducing clinical symptoms, pharmacologic therapies for AR that specifically reduce inflammatory cells and mediators -and therefore nasal congestion and other symptoms -should also improve sleep quality and overall quality of life (QOL). Intranasal corticosteroids (INS) are the current mainstay of therapy for AR. Results of a number of clinical trials demonstrate that INS effectively reduce nasal congestion and ocular symptoms, improve sleep quality, and decrease daytime somnolence. Intranasal corticosteroids have also proved to be effective in reducing symptoms of acute rhinosinusitis and nasal polyposis, both of which also negatively impact on sleep quality. Intranasal corticosteroids are considered safe due to their low systemic bioavailability.

show abstract

“…Various studies in the literature have indicated that nasal patency disorders should be treated as a potential risk factor for SDB development (24,25). For example, in a prospective study by Lofaso et al (26), it was stated that nasal patency disorders assessed on the basis of posterior rhinomanometry are independent risk factors for OSA development, although their impact was significantly weaker compared with the effect of obesity or facial bone abnormalities.…”

Section: Discussionmentioning

confidence: 99%

Nasopharyngeal chordoma in a patient with a severe form of sleep-disordered breathing: A case report

Radzikowska¹,

Gronkiewicz²,

Kukwa³

et al. 2015

Oncology Letters

View full text Add to dashboard Cite

Abstract. Nasopharyngeal chordoma is a rare type of malignant neoplasm that originates in the remnants of the notochord, a primitive tissue of embryonic origin preserved outside the axial skeleton. Approximately one-third of chordomas are located in the base of the skull, in the midline of the body. The slow growth rate of the tumor, which gradually fills the nasopharyngeal cavity, contributes to a delayed oncological diagnosis. Among its isolated and non-specific symptoms, the obstruction of the nasopharynx is dominant, thus, sleep-disordered breathing (SDB) may occur. The current study presents the case of a 32-year-old female patient who was incidentally diagnosed with a nasopharyngeal chordoma during a diagnostic examination for SDB. The diagnostic examination was performed as a part of a research program for pathologically obese patients who qualified for bariatric surgery. Following tumor resection, a significant improvement in various polysomnographic parameters occurred, including a decrease in the apnea hypopnea index from 53.5 to 6.4 and an increase in the mean saturation rate from 92.5 to 95%, confirming that an association exists between tumor obstruction of the nasopharynx and SDB. The incidental diagnosis of this rare type of neoplasm drew attention to diagnostic and therapeutic problems associated with nasopharyngeal chordomas. Furthermore, it indicated the necessity for the accurate laryngological examination of patients with SDB.

show abstract

Sleep and Breathing Disturbance Secondary to Nasal Obstruction

Cited by 221 publications

References 6 publications

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

Allergic rhinitis-induced nasal congestion: its impact on sleep quality

Nasopharyngeal chordoma in a patient with a severe form of sleep-disordered breathing: A case report

Contact Info

Product

Resources

About